Female mice of inbred strain CBA do not reject syngeneic male skin grafts even though they mount a T-cell response against the male-specific HY antigen. We show that local immunostimulation performed by injecting cytokines and Toll-like receptor ligands in close vicinity to the graft causes rejection. We feel that this approach should be tested in tumor-bearing human patients in combination with antitumor vaccination. Relief of intratumor immunosuppression may increase considerably the fraction of patients who respond to vaccination directed against tumor antigens recognized by T cells
We have established a model for the immunologic rejection of melanoma cells. Using a receptor-mediat...
The mechanisms of tumor rejection were investigated by using a therapeutic model system involving tr...
Tumor-associated antibodies are frequently detected in cancer patients. To ask whether the recognize...
The introduction is a review of the literature covering the different immunotherapeutic protocols te...
Breaking the state of immunological unresponsiveness of tumor-bearing individuals to cancer is a pre...
Most of the skin grafts from (K14hGH.FVB C57BL/6) F1 mice, which express foreign antigen (human grow...
Anticancer vaccines have not matched the clinical expectations projected from their ability to induc...
Approaches for T-cell-based immunotherapy that have shown substantial effects in clinical trials are...
Immunotherapy generally fails to induce tumour regression in spontaneously arising tumours. Failure ...
Tumor-destructing techniques, like radiofrequency ablation (RFA), allow eradication of large tumors....
Background: Although immunization with tumor antigens can eliminate many transplantable tumors in an...
Sensitized T lymphocytes can mediate potent antitumor effects when transferred to tumorbearing anima...
The incidence of tumor formation in MCA-treated skin grafted onto maximally immunosuppressed mice th...
Certain experimental tumours have been reported to be characterised by specific tumour antigens, and...
Understanding the behaviour of T cells in context of tumour responses is crucial for designing adopt...
We have established a model for the immunologic rejection of melanoma cells. Using a receptor-mediat...
The mechanisms of tumor rejection were investigated by using a therapeutic model system involving tr...
Tumor-associated antibodies are frequently detected in cancer patients. To ask whether the recognize...
The introduction is a review of the literature covering the different immunotherapeutic protocols te...
Breaking the state of immunological unresponsiveness of tumor-bearing individuals to cancer is a pre...
Most of the skin grafts from (K14hGH.FVB C57BL/6) F1 mice, which express foreign antigen (human grow...
Anticancer vaccines have not matched the clinical expectations projected from their ability to induc...
Approaches for T-cell-based immunotherapy that have shown substantial effects in clinical trials are...
Immunotherapy generally fails to induce tumour regression in spontaneously arising tumours. Failure ...
Tumor-destructing techniques, like radiofrequency ablation (RFA), allow eradication of large tumors....
Background: Although immunization with tumor antigens can eliminate many transplantable tumors in an...
Sensitized T lymphocytes can mediate potent antitumor effects when transferred to tumorbearing anima...
The incidence of tumor formation in MCA-treated skin grafted onto maximally immunosuppressed mice th...
Certain experimental tumours have been reported to be characterised by specific tumour antigens, and...
Understanding the behaviour of T cells in context of tumour responses is crucial for designing adopt...
We have established a model for the immunologic rejection of melanoma cells. Using a receptor-mediat...
The mechanisms of tumor rejection were investigated by using a therapeutic model system involving tr...
Tumor-associated antibodies are frequently detected in cancer patients. To ask whether the recognize...